These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 32219702)
1. The role of ErbB4 in cancer. Segers VFM; Dugaucquier L; Feyen E; Shakeri H; De Keulenaer GW Cell Oncol (Dordr); 2020 Jun; 43(3):335-352. PubMed ID: 32219702 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis. Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216 [TBL] [Abstract][Full Text] [Related]
3. The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein. Lucas LM; Dwivedi V; Senfeld JI; Cullum RL; Mill CP; Piazza JT; Bryant IN; Cook LJ; Miller ST; Lott JH; Kelley CM; Knerr EL; Markham JA; Kaufmann DP; Jacobi MA; Shen J; Riese DJ Pharmacol Rev; 2022 Jan; 74(1):18-47. PubMed ID: 34987087 [TBL] [Abstract][Full Text] [Related]
4. Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis. Fujiwara S; Ibusuki M; Yamamoto S; Yamamoto Y; Iwase H Breast Cancer; 2014 Jul; 21(4):472-81. PubMed ID: 23100016 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of ERBB family mRNA expression in breast carcinomas. Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037 [TBL] [Abstract][Full Text] [Related]
6. Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells. Canfield K; Li J; Wilkins OM; Morrison MM; Ung M; Wells W; Williams CR; Liby KT; Vullhorst D; Buonanno A; Hu H; Schiff R; Cook RS; Kurokawa M Cell Cycle; 2015; 14(4):648-55. PubMed ID: 25590338 [TBL] [Abstract][Full Text] [Related]
7. Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling. Wandinger SK; Lahortiga I; Jacobs K; Klammer M; Jordan N; Elschenbroich S; Parade M; Jacoby E; Linders JT; Brehmer D; Cools J; Daub H PLoS One; 2016; 11(1):e0146100. PubMed ID: 26745281 [TBL] [Abstract][Full Text] [Related]
8. Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer. Mitsui K; Yonezawa M; Tatsuguchi A; Shinji S; Gudis K; Tanaka S; Fujimori S; Sakamoto C BMC Cancer; 2014 Nov; 14():863. PubMed ID: 25416285 [TBL] [Abstract][Full Text] [Related]
9. The neuregulin-I/ErbB signaling system in development and disease. Britsch S Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114 [TBL] [Abstract][Full Text] [Related]
10. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation. Feroz K; Williams E; Riese DJ Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361 [TBL] [Abstract][Full Text] [Related]
11. Expression of the EGF receptor family members ErbB2, ErbB3, and ErbB4 in germinal zones of the developing brain and in neurosphere cultures containing CNS stem cells. Kornblum HI; Yanni DS; Easterday MC; Seroogy KB Dev Neurosci; 2000; 22(1-2):16-24. PubMed ID: 10657694 [TBL] [Abstract][Full Text] [Related]
13. The receptor tyrosine kinase ERBB4 is expressed in skin keratinocytes and influences epidermal proliferation. Hoesl C; Röhrl JM; Schneider MR; Dahlhoff M Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):958-966. PubMed ID: 29410073 [TBL] [Abstract][Full Text] [Related]
14. The ErbB/HER family of protein-tyrosine kinases and cancer. Roskoski R Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963 [TBL] [Abstract][Full Text] [Related]
15. Analysis of regulatory mechanism after ErbB4 gene mutation based on local modeling methodology. Chen CL; Zhao JW Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323039 [TBL] [Abstract][Full Text] [Related]
16. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas. Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875 [TBL] [Abstract][Full Text] [Related]
17. Role of ErbB4 in breast cancer. Sundvall M; Iljin K; Kilpinen S; Sara H; Kallioniemi OP; Elenius K J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):259-68. PubMed ID: 18454307 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of the four isoforms of receptor tyrosine kinase ErbB4, but not ErbB1, confers cardiomyocyte hypertrophy. Wang Z; Chan HW; Gambarotta G; Smith NJ; Purdue BW; Pennisi DJ; Porrello ER; O'Brien SL; Reichelt ME; Thomas WG; Paravicini TM J Cell Physiol; 2021 Dec; 236(12):8160-8170. PubMed ID: 34170016 [TBL] [Abstract][Full Text] [Related]
20. Somatic mutations of the ERBB4 kinase domain in human cancers. Soung YH; Lee JW; Kim SY; Wang YP; Jo KH; Moon SW; Park WS; Nam SW; Lee JY; Yoo NJ; Lee SH Int J Cancer; 2006 Mar; 118(6):1426-9. PubMed ID: 16187281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]